The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women

The utility of procollagen type 1 N-terminal propeptide (P1NP) in the management of metabolic bone diseases remains a subject of debate since the reference ranges are not rigorously established and fail to account for many of the preanalytical variables. We aimed to establish reference intervals for...

Full description

Bibliographic Details
Main Authors: Elma Kučukalić-Selimović, Amina Valjevac, Almira Hadžović-Džuvo
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2013-11-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/2337
_version_ 1797260920774197248
author Elma Kučukalić-Selimović
Amina Valjevac
Almira Hadžović-Džuvo
author_facet Elma Kučukalić-Selimović
Amina Valjevac
Almira Hadžović-Džuvo
author_sort Elma Kučukalić-Selimović
collection DOAJ
description The utility of procollagen type 1 N-terminal propeptide (P1NP) in the management of metabolic bone diseases remains a subject of debate since the reference ranges are not rigorously established and fail to account for many of the preanalytical variables. We aimed to establish reference intervals for P1NP level in healthy and osteoporotic postmenopausal females stratified by age, body mass index and menopausal duration. We also aimed to assess the relationship between P1NP and BMD. This cross-sectional study enrolled 183 postmenopausal females who were divided in osteoporosis group (N=93) and control group (N=90) with preserved bone mass based on BMD assessed by DXA. In the osteoporosis group median P1NP was significantly higher (51.7 ng / mL; 95%CI 43.2-53.7) compared to control group (38.9 ng/mL; 95%CI 34.2-43.9)(p<0.01). After controlling for age, BMI and years since menopause, there was significant inverse association between BMD and P1NP at the femoral neck (r=-0.18), total hip (r=-0.207) and lumbar spine (r=-0.236). There was no significant difference in P1NP concentration across quartiles of age in postmenopausal females. P1NP was significantly lower in obese postmenopausal females with preserved bone mass compared to normal weight and overweight females in control and in osteoporosis group. In conclusion, we showed that P1NP is inversely associated with BMD even after controlling for age, BMI and years since menopause. Although, P1NP is significantly higher in postmenopausal females with osteoporosis compared to postmenopausal females with preserved bone mass its low specificity does not warrant its utility is diagnosing osteoporosis.
first_indexed 2024-04-24T23:33:00Z
format Article
id doaj.art-e968ebccfd5d4af0b3e5e0ecebb9a3d8
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T23:33:00Z
publishDate 2013-11-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-e968ebccfd5d4af0b3e5e0ecebb9a3d82024-03-15T14:32:51ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2013-11-0113410.17305/bjbms.2013.2337216The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal womenElma Kučukalić-Selimović0Amina Valjevac1Almira Hadžović-Džuvo2Clinics for Nuclear Medicine, Clinical Center University of SarajevoDepartment for Physiology, Faculty of Medicine, University of SarajevoDepartment for Physiology, Faculty of Medicine, University of SarajevoThe utility of procollagen type 1 N-terminal propeptide (P1NP) in the management of metabolic bone diseases remains a subject of debate since the reference ranges are not rigorously established and fail to account for many of the preanalytical variables. We aimed to establish reference intervals for P1NP level in healthy and osteoporotic postmenopausal females stratified by age, body mass index and menopausal duration. We also aimed to assess the relationship between P1NP and BMD. This cross-sectional study enrolled 183 postmenopausal females who were divided in osteoporosis group (N=93) and control group (N=90) with preserved bone mass based on BMD assessed by DXA. In the osteoporosis group median P1NP was significantly higher (51.7 ng / mL; 95%CI 43.2-53.7) compared to control group (38.9 ng/mL; 95%CI 34.2-43.9)(p<0.01). After controlling for age, BMI and years since menopause, there was significant inverse association between BMD and P1NP at the femoral neck (r=-0.18), total hip (r=-0.207) and lumbar spine (r=-0.236). There was no significant difference in P1NP concentration across quartiles of age in postmenopausal females. P1NP was significantly lower in obese postmenopausal females with preserved bone mass compared to normal weight and overweight females in control and in osteoporosis group. In conclusion, we showed that P1NP is inversely associated with BMD even after controlling for age, BMI and years since menopause. Although, P1NP is significantly higher in postmenopausal females with osteoporosis compared to postmenopausal females with preserved bone mass its low specificity does not warrant its utility is diagnosing osteoporosis. https://www.bjbms.org/ojs/index.php/bjbms/article/view/2337procollagen type 1 N-terminal propeptidepostmenopausal femalesosteoporosisbone mineral density
spellingShingle Elma Kučukalić-Selimović
Amina Valjevac
Almira Hadžović-Džuvo
The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
Biomolecules & Biomedicine
procollagen type 1 N-terminal propeptide
postmenopausal females
osteoporosis
bone mineral density
title The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
title_full The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
title_fullStr The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
title_full_unstemmed The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
title_short The utility of procollagen type 1 N-terminal propeptide for the bone status assessment in postmenopausal women
title_sort utility of procollagen type 1 n terminal propeptide for the bone status assessment in postmenopausal women
topic procollagen type 1 N-terminal propeptide
postmenopausal females
osteoporosis
bone mineral density
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/2337
work_keys_str_mv AT elmakucukalicselimovic theutilityofprocollagentype1nterminalpropeptideforthebonestatusassessmentinpostmenopausalwomen
AT aminavaljevac theutilityofprocollagentype1nterminalpropeptideforthebonestatusassessmentinpostmenopausalwomen
AT almirahadzovicdzuvo theutilityofprocollagentype1nterminalpropeptideforthebonestatusassessmentinpostmenopausalwomen
AT elmakucukalicselimovic utilityofprocollagentype1nterminalpropeptideforthebonestatusassessmentinpostmenopausalwomen
AT aminavaljevac utilityofprocollagentype1nterminalpropeptideforthebonestatusassessmentinpostmenopausalwomen
AT almirahadzovicdzuvo utilityofprocollagentype1nterminalpropeptideforthebonestatusassessmentinpostmenopausalwomen